ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 417961 | Rec_0427362 | [A2,6,9, K3]SHa-COOH |
FAKGIAGMAGKLF |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram-positive |
Listeria ivanovii |
256 μM | MBC |
30813478 | - |
YES |
| 417962 | Rec_0427364 | Unnamed |
GTLKKARYNAQCQET |
synthetic construct [Synthetic] |
Anticancer |
- |
- | - |
- | US 2011/0159022 A1 |
NO |
| 417963 | Rec_0427365 | Lynronne-2 |
HLRRINKLLTRIGLYRHAFG |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Staphylococcus aureus RN4220 |
32 μg/mL | MIC |
29214045 | - |
YES |
| 417964 | Rec_0427672 | PKF273-791 |
XYVNVP |
synthetic construct [Synthetic] |
Protein-binding, Peptide-protein interaction, Structural binding, GRB2 SH2-domain binding |
growth factor receptor-bound protein 2 (GRB2) SH2 domain |
- | X-ray crystallography |
10090780 | - |
YES |
| 417965 | Rec_0427673 | Cehlshaac |
CEHLSHC |
synthetic construct [Synthetic] |
Antiviral, Andes virus infection inhibition, Surface glycoprotein binding |
Andes virus strain CHI-7913; surface glycoproteins Gn/Gc; Vero E6 cells |
38.47 % | ANDV infection inhibition by peptide-bearing phage; immunofluorescence assay (IFA) |
19515773 | - |
YES |
| 417966 | Rec_0427674 | Csaaerlnc |
CSERLNC |
synthetic construct [Synthetic] |
Antiviral, Andes virus infection inhibition, Surface glycoprotein binding |
Andes virus strain CHI-7913; surface glycoproteins Gn/Gc; Vero E6 cells |
40.13 % | ANDV infection inhibition by peptide-bearing phage; immunofluorescence assay (IFA) |
19515773 | - |
YES |
| 417967 | Rec_0427675 | Cmqsaaahc |
CMQSAHC |
synthetic construct [Synthetic] |
Antiviral, Andes virus infection inhibition, Surface glycoprotein binding |
Andes virus strain CHI-7913; surface glycoprotein Gn; Vero E6 cells |
59.66 % | Synthetic cyclic peptide ANDV infection inhibition in Vero E6 cells by IFA at 1 mM |
19515773 | - |
YES |
| 417968 | Rec_0427676 | Cpaashprc |
CPSHPRC |
synthetic construct [Synthetic] |
Antiviral screening hit (phage-displayed), Andes virus infection inhibition assay, Surface glycoprotein binding |
Andes virus strain CHI-7913; surface glycoprotein Gn; Vero E6 cells |
0 % | Synthetic cyclic peptide ANDV infection inhibition in Vero E6 cells by IFA at 1 mM |
19515773 | - |
YES |
| 417969 | Rec_0427677 | Ckfplnaac |
CKFPLNC |
synthetic construct [Synthetic] |
Antiviral, Andes virus infection inhibition, Surface glycoprotein binding |
Andes virus strain CHI-7913; surface glycoproteins Gn/Gc; Vero E6 cells |
22.89 % | ANDV infection inhibition by peptide-bearing phage; immunofluorescence assay (IFA) |
19515773 | - |
YES |
| 417970 | Rec_0427678 | Chgkaalac |
CHGKLAC |
synthetic construct [Synthetic] |
Antiviral, Andes virus infection inhibition, Surface glycoprotein binding |
Andes virus strain CHI-7913; surface glycoproteins Gn/Gc; Vero E6 cells |
27.22 % | ANDV infection inhibition by peptide-bearing phage; immunofluorescence assay (IFA) |
19515773 | - |
YES |
| 417971 | Rec_0427997 | Turgencin A |
GPKTKCKMACKLATCGKKPGGWKCKLCELGCDAV |
Synoicum turgens [Animal] |
Antimicrobial, Antibacterial, Anti-Gram-positive, Anti-Gram-negative, Anticancer, Cytotoxic |
- |
- | - |
31940927 | - |
NO |
| 417972 | Rec_0427998 | Turgencin B |
GIKEMLCNMACAQTVCKKSGGPLCDTCQCKALG |
Synoicum turgens [Animal] |
Antimicrobial, Antibacterial, Anti-Gram-positive, Anti-Gram-negative, Anticancer, Cytotoxic |
- |
- | - |
31940927 | - |
NO |
| 417973 | Rec_0430631 | Cdc27 melanoma antigenic peptide |
FSWAMDLDPKGA |
Homo sapiens [Animal] |
Cancer antigenic, T-cell epitope, Neoantigen |
HLA-DR4-restricted CD4+ T cells; autologous melanoma cells |
- | T cell recognition assay |
10334988 | - |
YES |
| 417974 | Rec_0430632 | COA-1 colorectal carcinoma antigenic peptide |
TLYQDDTLTLQAAG |
Homo sapiens [Animal] |
Cancer antigenic, T-cell epitope, Tumor-associated antigen |
CD4+ T cells; autologous colorectal carcinoma cells |
- | T cell recognition assay |
14583468 | - |
YES |
| 417975 | Rec_0430633 | CLPP melanoma antigenic peptide |
ILDKVLVHL |
Homo sapiens [Animal] |
Cancer antigenic, T-cell epitope, Tumor-associated antigen |
HLA-A2-restricted CD8+ T cells; autologous melanoma cells |
- | T cell recognition assay |
21216894 | - |
YES |
| 417976 | Rec_0430634 | FN1 melanoma antigenic peptide |
MIFEKHGFRRTTPP |
Homo sapiens [Animal] |
Cancer antigenic, T-cell epitope, Neoantigen |
MHC class II-restricted CD4+ T cells; autologous melanoma cells |
- | T cell recognition assay |
12045238 | - |
YES |
| 417977 | Rec_0430635 | ARTC1 melanoma antigenic peptide |
YSVYFNLPADTIYTN |
Homo sapiens [Animal] |
Cancer antigenic, T-cell epitope, Neoantigen |
CD4+ regulatory T cells; ARTC1-expressing melanoma cells |
- | T cell recognition assay |
15728473 | - |
YES |
| 417978 | Rec_0430636 | LDLR-fucosyltransferaseAS fusion protein melanoma antigenic peptide |
WRRAPAPGA |
Homo sapiens [Animal] |
Cancer antigenic, T-cell epitope, Fusion neoantigen |
MHC class II-restricted CD4+ T cells; autologous melanoma cells |
- | T cell recognition assay |
10330445 | - |
YES |
| 417979 | Rec_0430637 | LDLR-fucosyltransferaseAS fusion protein melanoma antigenic peptide |
PVTWRRAPA |
Homo sapiens [Animal] |
Cancer antigenic, T-cell epitope, Fusion neoantigen |
MHC class II-restricted CD4+ T cells; autologous melanoma cells |
- | T cell recognition assay |
10330445 | - |
YES |
| 417980 | Rec_0430638 | neo-PAP melanoma antigenic peptide |
RVIKNSIRLTL |
Homo sapiens [Animal] |
Cancer antigenic, T-cell epitope, Neoantigen |
MHC class II-restricted CD4+ T cells; melanoma cells |
- | T cell recognition assay |
12359760 | - |
YES |